Journal of Neuroinfectious Diseases
Open Access

The Journal of Neuroinfectious Diseases is celebrating its twelfth year in the field of Neuroscience publication and study, and it extends a welcoming invitation to all scientists, scholars, editors, and students to submit their most recent research results as full-length articles to this peer-reviewed journal. The journal is dedicated to providing stateof- the-art services to its scholars in order to improve their academic exposure.

Journal of Neuroinfectious Diseases was established in 2010 and is one of the most well-known journals in the Omics Journals community. It is a peer-reviewed journal that is well-known for its strong links with medical societies and institutions involved in Neurobiology study. As full-length scientific papers and case reports, the journal has been publishing the most recent discoveries in the fields of Bacteria Induced Neuropathies, Neurocystercercosis, Neuroepidemiology, Neurosyphilis, Neurovirology, and Rare Infectious Disease.

The journal has published several issues on Emerging Tolerance for Infectious Diseases, independent of any particular organ in the body.

With ten years under their belts, there are editor-in-chiefs who have been loyal throughout the magazine. This would be an excellent opportunity to thank them for their efforts. Herbert B Tanowitz, Professor in Department of Pathology and Medicine, Yeshiva University, USA and Joseph Ndung u, Professor, Head of Neglected Tropical Diseases Programme, Switzerland, Georges E. R. Grau Professor and Chair, Department of Vascular Immunology and Pathology, University of Sydney, Australia are one of them. Prof Hebert’s professional interests are laboratory investigates the pathogenesis of chagasic heart disease, caused by the parasite Trypanosoma cruzi. His key research project looks at the signalling mechanisms involved in cardiac remodelling as a result of T. cruzi infection. This research, he says, is looking into the impact of Neuroinfection on cell cycle regulatory proteins in vitro.

With the help of eminent writers, critics, and writers, the journal plans to publish the issue monthly this year, as well as a special issue.

The Journal of Neuroinfectious Diseases is dedicated to the ‘Creative Commons’ policy of publishing scholarly papers on a free access forum after a rigorous peer review, and is listed and indexed in authoritative indexing sites such as Index Copernicus Google Scholar.

On the verge of celebrating more than a decade in medical publication, the Journal of Neuroinfectious Diseases is waiving 20% of its paper production fees to stimulate quality research from around the world.

The Journal of Neuroinfectious Diseases is celebrating its twelfth year in the field of Neuroscience publication and study, and it extends a welcoming invitation to all scientists, scholars, editors, and students to submit their most recent research results as full-length articles to this peer-reviewed journal. The journal is dedicated to providing stateof-the-art services to its scholars in order to improve their academic exposure.

Journal of Neuroinfectious Diseases was established in 2010 and is one of the most well-known journals in the Omics Journals community. It is a peer-reviewed journal that is well-known for its strong links with medical societies and institutions involved in Neurobiology study. As full-length scientific papers and case reports, the journal has been publishing the most recent discoveries in the fields of Bacteria Induced Neuropathies, Neurocystercercosis, Neuroepidemiology, Neurosyphilis, Neurovirology, and Rare Infectious Disease. The journal has published several issues on Emerging Tolerance for Infectious Diseases, independent of any particular organ in the body. With ten years under their belts, there are editor-in-chiefs who have been loyal throughout the magazine.

This would be an excellent opportunity to thank them for their efforts. Herbert B Tanowitz, Professor in Department of Pathology and Medicine, Yeshiva University, USA and Joseph Ndung u, Professor, Head of Neglected Tropical Diseases Programme, Switzerland, Georges E. R. Grau Professor and Chair, Department of Vascular Immunology and Pathology, University of Sydney, Australia are one of them. Prof Hebert’s professional interests are laboratory investigates the pathogenesis of chagasic heart disease, caused by the parasite Trypanosoma cruzi. His key research project looks at the signalling mechanisms involved in cardiac remodelling as a result of T. cruzi infection.

This research, he says, is looking into the impact of Neuroinfection on cell cycle regulatory proteins in vitro. With the help of eminent writers, critics, and writers, the journal plans to publish the issue monthly this year, as well as a special issue. The Journal of Neuroinfectious Diseases is dedicated to the ‘Creative Commons’ policy of publishing scholarly papers on a free access forum after a rigorous peer review, and is listed and indexed in authoritative indexing sites such as Index Copernicus Google Scholar. On the verge of celebrating more than a decade in medical publication, the Journal of Neuroinfectious Diseases is waiving 20% of its paper production fees to stimulate quality research from around the world.